Allogeneic bone marrow transplantation for severe aplastic anaemia--the London experience.
Using the Seattle protocol with minor modifications, 23 patients with severe aplastic anaemia received allogeneic bone marrow transplants from HLA/mixed leucocyte culture matched sibs in three London centres between 1973 and 1977. Ten patients (43.5%) are alive 6 months to 5 years after transplantation, and are well with full haemopoietic reconstitution, two with autologous bone marrow recovery following the graft procedure. A failure of the marrow graft to take, or take followed by rejection occurred in 12 patients (52%). Failure of marrow recovery was associated with a high early mortality from bacterial or fungal infection. The only survivors amongst those who rejected the first graft were four patients in whom a subsequent graft from the same donor was successful, and two in whom autologous recovery occurred. Graft versus host disease (GVHD) occurred in seven patients, and was fatal in one case. The most frequent complication after successful engraftment was varicella-zoster infection which occurred in five patients and was fatal in one patient. The overall results compare favourably with those from other transplant centres, but the high rate of graft rejection and low incidence of GVHD differ from other series. The results should encourage further referral of patients with severe AA for bone marrow transplantation.
D000293:Adolescent; D000328:Adult; D000741:Anemia, Aplastic / Q000150:complications / Q000401:mortality / Q000601:surgery*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control; D016026:Bone Marrow Transplantation; D002644:Chickenpox / Q000401:mortality; D002648:Child; D002675:Child, Preschool; D005260:Female; D006084:Graft Rejection; D006087:Graft vs Host Reaction; D006562:Herpes Zoster / Q000401:mortality; D006801:Humans; D008131:London; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000401:mortality; D010356:Patient Isolation; D014184:Transplantation, Homologous
D000900:Anti-Bacterial Agents